Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

39.31
Delayed Data
As of Jun 23
 +0.13 / +0.33%
Today’s Change
28.15
Today|||52-Week Range
43.62
-2.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues210.0M220.3M227.8M228.1M
 
 
 
 
 
Cost of Goods Sold95.3M93.3M104.5M107.8M
 
 
 
 
 
Depreciation And Amortization22.5M22.7M22.3M22.2M
 
 
 
 
 
 
Operating ExpensesGross Income92.2M104.2M101.1M98.1M
 
 
 
 
 
General Expenses82.6M77.9M72.7M82.4M
 
 
 
 
 
Research And Development11.4M8.3M8.5M9.3M
 
 
 
 
 
Total Operating Expenses200.4M193.9M199.4M212.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.6M26.4M28.4M15.7M
 
 
 
 
 
Extraordinary Credit----2.0M--
 
 
Extraordinary Charge-17.7M-2.0M-7.2M-73.2M
 
 
 
 
 
Interest Expense On Debt1.9M1.6M4.3M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.1M22.8M18.9M-59.2M
 
 
 
 
 
Income Taxes-288.0K-3.0M-3.5M-8.0M
 
 
 
 
 
Net Income-10.3M19.8M15.4M-51.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.0M51.4M51.7M52.0M
 
 
 
 
 
Shares To Calculate EPS Diluted51.0M51.7M52.1M52.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.20$0.38$0.30-$0.98
 
 
 
 
 
EPS Diluted-$0.20$0.38$0.30-$0.98